A retrospective study to evaluate whether positivity of rheumatoid factor and anti-cyclic citrullinated peptide associated with response rate of infliximab, tocilizumab and abatacept in patients with rheumatoid arthritis.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2015
At a glance
- Drugs Abatacept (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Jul 2015 New trial record